Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,495 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $194.16 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $136.56 | 1 | $0 (2024) |
| Celltrion USA Inc. | $134.72 | 1 | $0 (2024) |
| GENZYME CORPORATION | $125.01 | 1 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $124.99 | 1 | $0 (2022) |
| Mylan Specialty L.P. | $124.99 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $119.99 | 1 | $0 (2024) |
| Novo Nordisk Inc | $119.99 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $119.35 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $641.25 | 5 | Janssen Pharmaceuticals, Inc ($136.56) |
| 2023 | $658.51 | 6 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($194.16) |
| 2022 | $194.94 | 2 | Alnylam Pharmaceuticals Inc. ($124.99) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $134.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: HCV | ||||||
| 05/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $136.56 | General |
| Category: Neuroscience | ||||||
| 01/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $119.99 | General |
| 09/27/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $169.16 | General |
| 09/27/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 07/20/2023 | Biogen, Inc. | Spinraza (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Neurology | ||||||
| 06/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $119.35 | General |
| Category: Oncology | ||||||
| 05/16/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Oncology | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $69.95 | General |
| 10/26/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 11 | 14 | $3,682 | $978.60 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 14 | $3,682 | $978.60 | 26.6% |
About Ann Steinwald, NP
Ann Steinwald, NP is a Critical Care Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043286875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ann Steinwald, NP has received a total of $1,495 in payments from pharmaceutical and medical device companies, with $641.25 received in 2024. These payments were reported across 13 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,495).
As a Medicare-enrolled provider, Steinwald has provided services to 11 Medicare beneficiaries, totaling 14 services with total Medicare billing of $978.60. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Location Buffalo, NY
- Active Since 02/23/2006
- Last Updated 08/28/2009
- Taxonomy Code 363LC0200X
- Entity Type Individual
- NPI Number 1043286875
Products in Payments
- SPRAVATO (Drug) $136.56
- ZYMFENTRA (Biological) $134.72
- SARCLISA (Biological) $125.01
- ONPATTRO (Drug) $124.99
- VOQUEZNA (Drug) $124.99
- YUPELRI (Drug) $124.99
- Epclusa (Drug) $119.99
- ERLEADA (Drug) $119.35
- Spinraza (Biological) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Buffalo
Dr. Nashat Rabadi, Md, MD
Critical Care Medicine — Payments: $599,049
Dr. Francois Fadell, M.d, M.D
Critical Care Medicine — Payments: $4,467
Kumar Shah, Md, MD
Critical Care Medicine — Payments: $2,553
Alberto Monegro, M.d, M.D
Critical Care Medicine — Payments: $1,847
Jessica Miller, Pa-C, PA-C
Critical Care Medicine — Payments: $1,328
Lucy Campbell, Md, MD
Critical Care Medicine — Payments: $195.92